Lenskart Solutions Limited has informed the Exchange about the Shareholders'' Letter and Results dated August 12, 2026

Lenskart Solutions Limited (Earlier known as Lenskart Solutions Private Limited) Corporate Office: Ground Floor, Vipul Tech Square, Golf Course Road, Sector- 43, Gurugram, Haryana 122009 Date: August 12, 2026 National Stock Exchange of India Limited BSE Limited The Listing Department, Department of Corporate Services, Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Fort, Mumbai - 400 051 Mumbai - 400 001 Scrip Symbol: LENSKART S c r i p C o d e : 5 4 4600 Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Shareholders’ Letter and Results dated August 12, 2026 Dear Sir/ Ma’am, In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed Shareholders’ Letter and Results dated August 12, 2026. Kindly take the same on record. The above information will also be hosted on the Company’s website at https://www.lenskart.com/corporate/investorrelations. Thanking you, Yours Sincerely, For Lenskart Solutions Limited (Formerly known as Lenskart Solutions Private Limited) Ashish Kumar Srivastava Company Secretary and Chief Compliance Officer Membership No.: F5325 Place: Gurugram Regd. Office: Plot No. 151, Okhla Industrial Estate, Phase III, New Delhi 110020 Website: www.lenskart.com, Email: compliance.officer@lenskart.com, Phone No: 0124 – 4293191 CIN — L33100DL2008PLC178355 Page 1 of 28 Letter from the Founders Dear Shareholders, Last year, we went public. Many saw an eyewear company - good stores, improving EBITDA. That is a fair first view of any newly listed company. Now we would like to share the fuller story - because what thousands of Lenskartians have spent a decade building is, we believe, one of India's leading global consumer companies in the making, and it deserves to be seen as a whole. First, the quarter. Revenue grew 33.6% YoY, EBITDA (pre-IndAS 116) grew 95.0%, and PAT grew 2.8x to ₹228 Cr. Put differently: a third more revenue; double the EBITDA; nearly triple the PAT - compounding is accelerating. Behind the financials, the engine: 0.7 Cr eye tests (+39.8% YoY), India SSSG of 18.3%, and volumes up 25.7% in line with our past average. Consolidated product margin crossed 70% for the first time. Measure us over years, not quarters; we intend to be more demanding of ourselves than you are of us. We see our role as creating the market, not competing in it. Every single day, roughly 35,000 Indians discover at Lenskart, for the first time in their lives, that they cannot see clearly - 63 lakh eye tests in India this quarter, over 1 Cr first-ever tests in FY26. That is a market being born - daily, measurably, in our stores. Much of this is by design: for a decade we have built every layer ourselves - the technology, the manufacturing, the supply chain, the optometry, the brands, the data, the customer trust. India has not bought its glasses yet. ~94 Cr Indians will need eyeglasses - and our ambition is to serve every one of them: every income, every age, every town. This is not a market to capture; it is a market to build, and we have spent a decade assembling the elements to build it. The proof is in this quarter itself: our largest-ever number of customers in the Real Bharat - ₹500 glasses, lenses and warranty included, sold profitably through Hustlr Club. At the same time, glasses with high-end Rodenstock and Tokai lenses, with progressive lenses at ₹30,000, did ~₹250 Cr annually. Similarly, glasses with premium Owndays lenses, a business that did not exist in India two years ago, did over ₹1,500 Cr annual sales. Two confessions. It took us too long to crack the ₹500 pair - the customer was ready; our costs were not. And we underestimated how fast our own customers would premiumize. We do not intend to repeat either mistake. What we built for India already serves the world - Singapore to Tokyo to Riyadh. This quarter, International grew 38% with EBITDA (pre-IndAS 116) margin crossing 10%. The question mark is gone; what remains is scale. Owndays is one of Asia's most respected brands; Meller, a US$35 Mn brand when we acquired it, is tracking to be a ~US$70 Mn brand - its Paris signature store draws a daily queue, with London next. Could Meller be the Ray- Ban of the future? I don't know - but the potential is there. Our aspiration, held with humility, is to build the world's most relevant eyewear company. The frontier ahead sits on the face. Our self-eye test entered pilot stores this quarter. India trains barely a few thousand optometrists a year; you cannot train your way to a billion eye tests – you have to engineer it. When one optometrist’s skill can reach a thousand rooms, access stops being rationed - and a billion tested eyes stops being a dream and becomes a schedule. B by Lenskart is live – 80,000+ sign-ups, smart glasses shipping daily. Eyewear sits on the face 12 hours a day - no device is closer to a human. Owning the design, the lens, the frame, the diagnostics, and the AI gives us a rare seat at the intersection of eyecare, AI, personal health, and data. We set out to sell eyeglasses. It was always a dream - to change how a billion people see and experience the world. Today that dream has a shape: the infrastructure of vision, built for those no one has ever served. Few companies get to attempt this. It is still Day Zero. - Peyush Bansal Page 2 of 28 Key Financial Highlights Key Performance Insights • A third more revenue; double the post-rent EBITDA (pre-IndAS 116); nearly triple the PAT - Growth remained broad-based: India grew 30.7% YoY, International 38.0% • Product Margin crossed 70% (consolidated) for the first time - 70.3% in Q1 FY27 vs 68.7% a year ago - and sustained even with the INR depreciating against the RMB; India reached 64.2% in Q1 FY27 vs 63.4% in Q1 FY26, and International to 77.1% vs 75.9% • EBITDA (pre-IndAS 116) margin reached 13.3% vs 9.1% in Q1 FY26. EBITDA margin expanded to 21.7% from 18.0%, with India at 21.4% and International at 21.9% • PAT of ₹228 Cr in a single quarter - the whole of FY26 was ~₹530 Cr, and Q1 FY26 was ₹81 Cr. PAT margin expanded 443 bps YoY to 8.4% from 4.0% • Profit is converting into cash: ₹297 Cr of operating cash flow was higher than ~₹207 Cr of capex - stores (₹75 Cr) and Hyderabad-led step-up in plant (₹132 Cr) - leaving net cash flow pre-M&A and Equity of ₹116 Cr • ROCE improved to 23.2% in Q1 FY27 vs 14.6% for FY26, driven by EBIT growth and disciplined capital allocation Notes: • In line with the Prospectus, all numbers presented in the Shareholders’ Letter are based on Proforma Financials (except ROCE, Net working capital days and Cash Flow, or unless stated otherwise), providing a clear like-for-like comparison. Proforma adjusts for the recent M&A, specifically the consolidation of the master-franchisee - Dealskart, GeoIQ and international acquisition of Meller: from Q3 FY26 onward, Proforma and Reported financials are identical. • EBITDA is after considering ESOP costs and R&D expenses, and it excludes Other Income. Page 3 of 28 Key Operating Highlights Key Performance Insights • India delivered SSSG of 18.3% in Q1 FY27 - strong performance across Metro, Tier 1, and Tier 2+ markets; SPSG reached 24.3% in Q1 FY27 • 132 net new stores added in Q1 FY27 (vs 83 in Q1 FY26), taking total active stores to 3,459. In India, added 116 net new stores (83 in Tier 2+), entering 50 new cities. In International, added 16 net new stores • Lenskart Gold active members reached 93.5 Lakhs in Q1 FY27, with Gold subscription fees of ₹66 Cr, up 57.4% YoY • 0.7 Cr eye tests conducted in Q1 FY27 (+39.8% YoY). India eye tests grew +42.7% YoY to 0.6 Cr with about half being first-time eye exams • 25.7% volume growth YoY in Q1 FY27. Volume remains an important metric we guide shareholders to track • India ASP grew 6.4% YoY to ₹1,856 in Q1 FY27, led by premiumisation of mix; Internati [Showing first 8,000 characters — download PDF for full document]